Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

Cartherics and the Coronavirus

By Karen Loudon / March 24, 2020
A message from Cartherics CEO Alan Trounson 'Due to the escalation of public health measures to prevent the spread of...
Read More

Cartherics develops people as well as ideas

By Karen Loudon / March 20, 2020
Three cheers for PhD student Rasa Islam By Leigh Dayton, Cartherics Communication Advisor She started last March and now Cartherics’ first...
Read More

Cartherics welcomes a new team member with a sigh of relief ……

By Karen Loudon / March 10, 2020
By Leigh Dayton When she started in January, the word spread rapidly. Publications Officer Aleta Pupovac was hired to use...
Read More